Escambray ENGLISH EDITION
Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.»
Over 31,000 Cuban Patients Benefit from Heberprot-P
